NUGENOI: Nutrigenomics And Children Obesity: A Moderate Weight Loss Intervention Study

Sponsor
Clinica Universidad de Navarra, Universidad de Navarra (Other)
Overall Status
Completed
CT.gov ID
NCT01329367
Collaborator
Hospital Virgen del Camino (Other)
42
2
3
122
21
0.2

Study Details

Study Description

Brief Summary

The consumption of diets enriched in proteins (legumes and fish) or antioxidant (fruits and vegetables) could have beneficial effects beyond those of the caloric restriction on biomarkers of the inflammatory and oxidative status. OBJECTIVE: To address the effect of a 10-week dietary intervention aimed to weight loss in obese or overweight children (7-15 aged) on genomics, particularly the changes in the expression of genes related to the inflammatory status and oxidative stress. METHODOLOGY: 44 Navarra children and adolescents of both sexes from Pediatric Endocrinology Services at different Hospitals in Pamplona will be recruited.

The effect of the intensive consumption of different groups of food will be evaluated:

legumes and fish ( diets in proteins) and vegetable and fruits (rich diets in antioxidants). Before and after the intervention, the following items will be analyzed: (1) the diet of the subjects, (2) body composition and 3 magnitudes related to biological and development parameters, being: (3) lipid and metabolic phenotypic profile; (4) markers of the inflammatory status and oxidative stress, and (5) the genomic profile. The dietary programme will be implemented both in group workshops addresseded to patients and their family, and in individual sessions with the pediatricians and/or registered dieticians. Finally, the programme efficacy will be evaluated by the scoreboards integrated in the 5 variables already mentioned.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Control group
  • Behavioral: Protein group
  • Behavioral: Antioxidant group
N/A

Detailed Description

A longitudinal intervention study in 44 overweight and obese adolescents (23 females and 21 males; mean age 11.5 years) for 10 weeks based on a calorie restricted diet (20-40%) according to obesity degree.

Study Design

Study Type:
Interventional
Actual Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efecto de Una Intervención Dietética Sobre La Expresión De Genes De La Inflamación Y El Estrés Oxidativo En Niños Obesos
Study Start Date :
Jan 1, 2010
Actual Primary Completion Date :
Sep 1, 2011
Actual Study Completion Date :
Mar 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control group

Control group: Subjects will receive Nutritional education together with weight management counselling for overweight and obesity. -10 weekly personal interviews with a registered nutritionist for body weight control.

Behavioral: Control group
Subjects will receive Nutritional education together with weight management counselling for overweight and obesity. -10 weekly personal interviews with a registered nutritionist for body weight control.

Experimental: Protein group

Protein group: Participants will receive Nutritional education and personalised structured meal plan with a calorie restricted diet (20-40% of the subject's energy expenditure at baseline) according to obesity degree, encouraging high consumption of legumes and fish (protein rich diets). -10 weekly personal interviews with a registered nutritionist for body weight control.

Behavioral: Protein group
Participants will receive Nutritional education and personalised structured meal plan with a calorie restricted diet (20-40% of the subject's energy expenditure at baseline) according to obesity degree, encouraging high consumption of legumes and fish (protein rich diets). -10 weekly personal interviews with a registered nutritionist for body weight control.

Experimental: Antioxidant group

Antioxidant group: Participants will receive Nutritional education and personalized structured meal plan with a calorie restricted diet (20-40% of the subject's energy expenditure at baseline) according to obesity degree, encouraging high consumption of fruits and vegetables (antioxidant rich diets). -10 weekly personal interviews with a registered nutritionist for body weight control.

Behavioral: Antioxidant group
Participants will receive Nutritional education and personalized structured meal plan with a calorie restricted diet (20-40% of the subject's energy expenditure at baseline) according to obesity degree, encouraging high consumption of fruits and vegetables (antioxidant rich diets). -10 weekly personal interviews with a registered nutritionist for body weight control.

Outcome Measures

Primary Outcome Measures

  1. Body masss index [week 0]

    Body mas index will be measured at the beginning of the study (week 0), at week 5 and week 10 (end of the study).

Secondary Outcome Measures

  1. Basal glucose concentration [week 10]

    Basal glucose concentration will be measured at the beginning of the study (week 0)and week 10 (end of the study).

  2. Insulin concentrations [week 0]

    Insulin concentrations will be analysed at week 0, and 10.

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 15 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children between 7 and 15 years

  • Body Mass Index (BMI) higher to 97 percentile. (Cole et al, 2000)*

  • Cole TJ, Belizzy MC, Flegal KM, Dietz WH. Br Med J 2000; 320: 1-6.

Exclusion Criteria:
  • Use of prescription medication

  • To suffer from any major psychiatry or neurological disease, bulimia nervosa, familiar hypercholesterolemia or any major cardiac, or respiratory metabolic disease.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UNavarre Pamplona Navarra Spain 31008
2 University of Navarre Pamplona Navarra Spain 31008

Sponsors and Collaborators

  • Clinica Universidad de Navarra, Universidad de Navarra
  • Hospital Virgen del Camino

Investigators

  • Principal Investigator: Amelia Marti, PhD, BPharm, University of Navarra
  • Study Director: Cristina Azcona, MD, University of Navarre Clinic
  • Study Chair: Maria Chueca, MD, Virgen del Camino Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Clinica Universidad de Navarra, Universidad de Navarra
ClinicalTrials.gov Identifier:
NCT01329367
Other Study ID Numbers:
  • NUGENOI-UN
First Posted:
Apr 5, 2011
Last Update Posted:
Mar 24, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Clinica Universidad de Navarra, Universidad de Navarra
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 24, 2020